Financial statements Sanford Biotech
Balance sheet of Sanford Biotech
Company age:
Age:
8 y. 5 m. 13 d.
Share capital:
Share capital:
5 000 PLN
Balance sheet data of SANFORD BIOTECH
|
Year
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|
| Total assets | 3 905,80 | 6 266,60 | 21 077,00 | 11 067,40 |
| A. Fixed assets | 0,00 | 0,00 | 0,00 | 0,00 |
| B. Current assets | 3 905,80 | 6 266,60 | 21 077,00 | 11 067,40 |
| C. Share capital contributions (basic funds) | - | - | - | - |
| D. Own shares (stocks) | - | - | - | - |
| Total liabilities | 3 905,80 | 6 266,60 | 21 077,00 | 11 067,40 |
| A. Equity | -10 599,15 | -22 865,69 | -40 341,51 | -51 178,22 |
| B. Liabilities and provisions for liabilities | 14 504,95 | 29 132,29 | 61 418,51 | 62 245,62 |
| I. Long-term liabilities | - | - | - | - |
| II. Short-term liabilities | - | - | - | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.